# SUPPRELIN LA

NDC: 67979-002
Generic name: histrelin acetate
Labeler / Manufacturer: Endo USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: IMPLANT
Routes: SUBCUTANEOUS
Marketing started: 20070531

FDA application: NDA022058

## Active ingredients

- HISTRELIN ACETATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67979-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67979-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8fb000e-3cc9-4803-b71d-2cc597661977